(Q33387221)

English

EORTC study 26041-22041: phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastoma

scientific article

Statements

EORTC study 26041-22041: phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastoma (English)
0 references
0 references
27 November 2009

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit